- Home
- MURA vs PETS Comparison
MURA vs PETS Comparison
Compare MURA & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MURA | PETS |
|---|---|---|
| Founded | 2013 | 1996 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | | Retail-Drug Stores and Proprietary Stores |
| Sector | | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.0M | 63.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MURA | PETS |
|---|---|---|
| Price | $2.03 | $3.01 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 2 | 1 |
| Target Price | ★ $6.00 | $3.20 |
| AVG Volume (30 Days) | 224.8K | ★ 6.9M |
| Earning Date | 11-06-2025 | 02-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $226,972,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.95 | $1.57 |
| 52 Week High | $4.74 | $6.08 |
Technical Indicators
Market Signals| Indicator | MURA | PETS |
|---|---|---|
| Relative Strength Index (RSI) | 40.39 | 72.48 |
| Support Level | $2.06 | $1.69 |
| Resistance Level | $2.10 | $4.05 |
| Average True Range (ATR) | 0.01 | 0.24 |
| MACD | -0.01 | 0.15 |
| Stochastic Oscillator | 25.00 | 55.24 |
Price Performance
Historical ComparisonAbout MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.